Substituedaryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors

Details for Australian Patent Application No. 2009205539 (hide)

Owner Allergan.Inc

Inventors Chow, Ken; Bhat, Smita S.; Heidelbaugh, Todd M.; Sinha, Santosh C.

Agent Davies Collison Cave

Pub. Number AU-A-2009205539

PCT Pub. Number WO2009/091735

Priority 61/022,148 18.01.08 US

Filing date 13 January 2009

Wipo publication date 23 July 2009

International Classifications

C07D 233/64 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/415 (2006.01) - 1,2-Diazoles

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

12 August 2010 PCT application entered the National Phase

  PCT publication WO2009/091735 Priority application(s): WO2009/091735

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009205544-Backup paging for wireless communication

2009205529-Block and bleed valve assembly